Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential traditional Chinese medicine program versus Seretide for bronchial asthma
ChiCTR-TRC-13003909Phase 4Completed
- Sponsor
- The Second Hospital of Tianjin Medical University
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of salmeterol + fluticasone in asthma (2 arms), sponsored by The Second Hospital of Tianjin Medical University. Primary endpoints: Eosinophil cationic protein, Histone deacetylase and 2 more. Started Dec 2013; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR-TRC-13003909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003909.